The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.
本发明涉及式(I)的化合物,其作为丙型肝炎病毒(HCV)NS5A
抑制剂有用,这些化合物的合成以及使用这些化合物来抑制HCV NS5A活性,治疗或预防HCV感染以及在基于细胞的系统中抑制HCV病毒复制和/或病毒产生。